# Eris Lifesciences to acquire remaining 30% stake in Swiss Parenterals

Eris Lifesciences agreed to acquire the balance 30% stake in Swiss Parenterals for ₹423.3 crore via a share swap, making it a wholly-owned subsidiary. The deal is expected to close before March 31, 2026.

- Type: Acquisition
- Announced: 2025-11-25
- Where: India
- Value: $51.0M (4.23B INR)
- Status: announced
- Products: parenteral products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eris Lifesciences](https://endata.com/companies/42256.md) (acquirer)
- [Swiss Parenterals](https://endata.com/companies/75617.md) (target)

## Sources

- [indiainfoline.com](https://www.indiainfoline.com/news/companies/eris-lifesciences-to-acquire-balance-30-stake-in-swiss-parenterals), 2025-11-25: "This acquisition will strengthen operational control, improving overall cost efficiencies and enabling full financial consolidation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.